Amgen

Amgen (AMGN) Inventory Spending Analysis From 2012 To 2016

This report provides the last five years inventory spending analysis of Amgen Inc (AMGN) from 2012 to 2016. Amgen invested a total of $2.7 billion on inventories during 2016. Amgen generated a total of $23 billion revenues during 2016. As a percentage of revenues, Amgen invested 11.9% of its total revenues on inventories during 2016. The inventory numbers are for the fiscal year ending in December.

Amgen (AMGN) Cost of Sales (COGS) Analysis From 2012 To 2016

This report provides the last five years cost of sales (COGS) analysis of Amgen Inc (AMGN) from 2012 to 2016. Amgen spent a total of $4.2 billion on COGS during 2016. Amgen generated a total of $23 billion revenues during 2016. As a percentage of revenues, Amgen spent 18.1% of its total revenues on COGS during 2016. The cost of sales (COGS) numbers are for the fiscal year ending in December.

Amgen (AMGN) Business Analysis – Analyze Historical Performance, Strategic Priorities, And Business Improvement Opportunities...

Amgen Inc with $23 billion revenues in the year 2016 was the number 3 Biotechnology company. Read this report to know the top competitors of Amgen and identify growth and cost optimization opportunities of Amgen

Amgen (AMGN) Revenues And Revenue Growth From 2012 To 2016

This report provides the last five years revenues and revenue growth of Amgen Inc (AMGN) from 2012 to 2016. Amgen generated a total of $23 billion revenues during 2016. Amgen reported a revenue growth of 6.1% year-over-year during 2016. The revenues and the revenue growth correspond to the fiscal year ending in December.

Amgen (AMGN) Net Profit And Net Margin From 2012 To 2016

This report provides the last five years net profit and net margin of Amgen Inc (AMGN) from 2012 to 2016. Amgen reported a total net income of $7.7 billion during 2016. Amgen generated a total of $23 billion revenues during 2016. Amgen net profit margin was 33.6% during 2016. The net profit and the net profit margin correspond to the fiscal year ending in December.

Amgen (AMGN) Property, Plant & Equipment (PP&E) Investment Analysis From 2012 To 2016

This report provides the last five years property, plant & equipment (PP&E) investment analysis of Amgen Inc (AMGN) from 2012 to 2016. Amgen invested a total of $5 billion on property, plant & equipment (PP&E) activities during 2016. Amgen generated a total of $23 billion revenues during 2016. As a percentage of revenues, Amgen invested 21.6% of its total revenues on PP&E activities during 2016. The PP&E investment numbers are for the fiscal year ending in December.

Amgen (AMGN) Accounts Receivable (A/R) Analysis From 2012 To 2016

This report provides the last five years Accounts Receivable (A/R) analysis of Amgen Inc (AMGN) from 2012 to 2016. Amgen invested a total of $3.2 billion on accounts receivable during 2016. Amgen generated a total of $23 billion revenues during 2016. As a percentage of revenues, Amgen invested 13.8% of its total revenues on accounts receivable during 2016. The accounts receivable numbers are for the fiscal year ending in December.

Amgen (AMGN) Revenues And Revenue Growth From 2002 To 2016

This report provides the last fifteen years revenues and revenue growth of Amgen Inc (AMGN) from 2002 to 2016. Amgen generated a total of $23 billion revenues during 2016. Amgen reported a revenue growth of 6.1% year-over-year during 2016. The revenues and the revenue growth correspond to the fiscal year ending in December.

Amgen (AMGN) Net Profit And Net Margin From 2002 To 2016

This report provides the last fifteen years net profit and net margin of Amgen Inc (AMGN) from 2002 to 2016. Amgen reported a total net income of $7.7 billion during 2016. Amgen generated a total of $23 billion revenues during 2016. Amgen net profit margin was 33.6% during 2016. The net profit and the net profit margin correspond to the fiscal year ending in December.

Amgen (AMGN) Research & Development (R&D) Spending Analysis From 2012 To 2016

This report provides the last five years research and development (R&D) expenses of Amgen Inc (AMGN) from 2012 to 2016. Amgen spent a total of $3.8 billion on research and development (R&D) activities during 2016. Amgen generated a total of $23 billion revenues during 2016. As a percentage of revenues, Amgen spent 16.7% of its total revenues on R&D activities during 2016. The R&D spending numbers are for the fiscal year ending in December.